We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.66%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$15.1B
AUM Growth
+$742M
Cap. Flow
-$196M
Cap. Flow %
-1.3%
Top 10 Hldgs %
36.33%
Holding
1,380
New
61
Increased
578
Reduced
366
Closed
37

Top Buys

Rank Stock Value
1
SPG icon
Simon Property Group
SPG
+$105M
2
SUI icon
Sun Communities
SUI
+$103M
3
IRM icon
Iron Mountain
IRM
+$96M
4
KIM icon
Kimco Realty
KIM
+$95.3M
5
MPT
Medical Properties Trust
MPT
+$80.5M

Top Sells

Rank Stock Value
1
PSA icon
Public Storage
PSA
+$213M
2
WELL icon
Welltower
WELL
+$143M
3
REXR icon
Rexford Industrial Realty
REXR
+$139M
4
DLR icon
Digital Realty Trust
DLR
+$40.5M
5
INVH icon
Invitation Homes
INVH
+$37.1M

Sector Composition

Rank Sector Weight
1 Real Estate 54.29%
2 Technology 12.23%
3 Consumer Discretionary 4.83%
4 Communication Services 4.52%
5 Healthcare 4.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IOVA icon
1151
Iovance Biotherapeutics
IOVA
$2.19B
$6K ﹤0.01%
877
– –
IRWD icon
1152
Ironwood Pharmaceuticals
IRWD
$644M
$6K ﹤0.01%
573
– –
MRVI icon
1153
Maravai LifeSciences
MRVI
$987M
$6K ﹤0.01%
490
– –
RCKT icon
1154
Rocket Pharmaceuticals
RCKT
$355M
$6K ﹤0.01%
304
– –
RLAY icon
1155
Relay Therapeutics
RLAY
$4.06B
$6K ﹤0.01%
486
– –
XNCR icon
1156
Xencor
XNCR
$1.47B
$6K ﹤0.01%
222
– –
ZNTL icon
1157
Zentalis Pharmaceuticals
ZNTL
$321M
$6K ﹤0.01%
212
– –
ARVN icon
1158
Arvinas
ARVN
$530M
$5K ﹤0.01%
198
– –
AUPH icon
1159
Aurinia Pharmaceuticals
AUPH
$1.96B
$5K ﹤0.01%
528
– –
BCRX icon
1160
BioCryst Pharmaceuticals
BCRX
$2.43B
$5K ﹤0.01%
692
– –
DBC icon
1161
Invesco DB Commodity Index Tracking Fund
DBC
$1.67B
$5K ﹤0.01%
200
– –
GERN icon
1162
Geron
GERN
$949M
$5K ﹤0.01%
1,407
– –
IDYA icon
1163
IDEAYA Biosciences
IDYA
$3.54B
$5K ﹤0.01%
193
– –
KYMR icon
1164
Kymera Therapeutics
KYMR
$9.05B
$5K ﹤0.01%
221
– –
LGND icon
1165
Ligand Pharmaceuticals
LGND
$5.96B
$5K ﹤0.01%
63
– –
MRUS
1166
DELISTED
Merus
MRUS
$5K ﹤0.01%
186
– –
PTGX icon
1167
Protagonist Therapeutics
PTGX
$8.72B
$5K ﹤0.01%
163
– –
REPL icon
1168
Replimune Group
REPL
$724M
$5K ﹤0.01%
200
– –
RXRX icon
1169
Recursion Pharmaceuticals
RXRX
$1.6B
$5K ﹤0.01%
731
-7,680
-91% -$53.7K
SANA icon
1170
Sana Biotechnology
SANA
$913M
$5K ﹤0.01%
767
– –
SNDX icon
1171
Syndax Pharmaceuticals
SNDX
$1.82B
$5K ﹤0.01%
242
– –
VRNA
1172
DELISTED
Verona Pharma
VRNA
$5K ﹤0.01%
244
– –
INBX
1173
DELISTED
Inhibrx, Inc. Common Stock
INBX
$5K ﹤0.01%
175
– –
ADPT icon
1174
Adaptive Biotechnologies
ADPT
$3.61B
$4K ﹤0.01%
530
– –
ANIP icon
1175
ANI Pharmaceuticals
ANIP
$1.78B
$4K ﹤0.01%
70
– –
45 46
47
48 49

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2023 Portfolio in Review

As of Q2 2023, Daiwa Securities Group held 1,380 positions worth $15.1B, up 5.2% from $14.4B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Daiwa Securities Group's Q2 2023 filing shows 61 new, 578 increased, 366 reduced and 37 closed positions. Its largest new stake was Applovin: 95,413 shares worth $2.46M. The largest sale was Public Storage, an estimated $213M.

By sector, the portfolio is most concentrated in Real Estate at 54% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q2 2023 buy was Applovin: 95,413 shares worth $2.46M.
  • Daiwa Securities Group added most to Simon Property Group in Q2 2023, an estimated $105M increase.
  • Daiwa Securities Group's biggest Q2 2023 reduction was Public Storage, cutting an estimated $213M.
  • Daiwa Securities Group fully exited BWX Technologies in Q2 2023, selling an estimated $6.7M.
  • Daiwa Securities Group's ten largest holdings make up 36% of its $15.1B portfolio in Q2 2023.
  • Daiwa Securities Group opened 61 new positions and closed 37 in Q2 2023.
  • Daiwa Securities Group's portfolio value rose 5.2% quarter-over-quarter to $15.1B.

Based on Daiwa Securities Group's 13F filing for Q2 2023, filed 31 Jul 2023.